NCT03604757View on ClinicalTrials.gov

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

December 19, 2019

Study Completion Date

December 19, 2019

Conditions
Prostate Cancer
Interventions
DRUG

68Ga-PSMA-617 PET/CT

PET/CT Imaging with 68Ga-PSMA-617 injection

DRUG

68Ga-RM2 PET/CT

PET/CT Imaging with 68Ga-RM2 injection

Trial Locations (1)

33076

Bordeaux University Hospital, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03604757 - 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks | Biotech Hunter | Biotech Hunter